| Fund ID | 805-1759306039 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | Yes |
| Feeder fund | No |
| Fund of funds | Yes |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 100% |
| Owned by funds of funds | 100% |
| Owned by non-U.S. persons | 31% |
| Fund | Type | Gross assets |
|---|---|---|
| Highvista (offshore) Ltd. | Hedge | $669.5M |
| Highvista I Limited Partnership | Hedge | $634.2M |
| Highvista 1.5 (offshore) Ltd | Hedge | $630.4M |
The stated minimum investment is $5 million.
Highvista Biotechnology Master Fund LP is managed by Highvista Strategies LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.